507 results on '"Jylhävä, Juulia"'
Search Results
2. Interplay of body mass index and metabolic syndrome: association with physiological age from midlife to late-life
3. Prevalence and Implications of Frailty in Older Adults With Incident Inflammatory Bowel Diseases: A Nationwide Cohort Study.
4. Clinical biomarker-based biological aging and risk of cancer in the UK Biobank
5. Longitudinal associations between use of antihypertensive, antidiabetic, and lipid-lowering medications and biological aging
6. Can frailty scores predict the incidence of cancer? Results from two large population-based studies
7. Recent developments in frailty identification, management, risk factors and prevention: A narrative review of leading journals in geriatrics and gerontology
8. Circulating cell-free DNA in health and disease — the relationship to health behaviours, ageing phenotypes and metabolomics
9. Adiposity and the risk of dementia: mediating effects from inflammation and lipid levels
10. Genetically and environmentally predicted obesity in relation to cardiovascular disease: a nationwide cohort study
11. Prevalence and Implications of Frailty in Older Adults With Incident Inflammatory Bowel Diseases: A Nationwide Cohort Study
12. Genetic influences, lifestyle and psychosocial aspects in relation to metabolically healthy obesity and conversion to a metabolically unhealthy state.
13. Is Cancer Associated With Frailty? Results From a Longitudinal Study of Old Danish Twins.
14. COVID-19 prevalence and mortality in longer-term care facilities
15. Protein Nutritional Status and Frailty: A Mendelian Randomization Study
16. Frailty in midlife as a predictor of changes in body composition from midlife into old age: a longitudinal birth cohort study
17. Clinical biomarkers and associations with healthspan and lifespan: Evidence from observational and genetic data
18. A geroscience approach for Parkinson’s disease: Conceptual framework and design of PROPAG-AGEING project
19. Deciphering the genetic and epidemiological landscape of mitochondrial DNA abundance
20. Temporal Dynamics of Epigenetic Aging and Frailty From Midlife to Old Age.
21. Lifestyle-related factors in late midlife as predictors of frailty from late midlife into old age: a longitudinal birth cohort study
22. Effects from medications on functional biomarkers of aging in three longitudinal studies of aging in Sweden
23. Epigenome‐wide analysis of frailty: Results from two European twin cohorts
24. Effects from medications on functional biomarkers of aging in three longitudinal studies of aging in Sweden
25. Replicating associations between DNA methylation and body mass index in a longitudinal sample of older twins
26. Epigenome-wide association study of level and change in cognitive abilities from midlife through late life
27. Frailty and the risk of dementia: is the association explained by shared environmental and genetic factors?
28. Fcμ receptor as a Costimulatory Molecule for T Cells
29. Longitudinal changes in the genetic and environmental influences on the epigenetic clocks across old age: Evidence from two twin cohorts
30. Interplay of body mass index and metabolic syndrome: association with physiological age from midlife to late-life
31. Use of Electronic Medical Records (EMR) in Gerontology: Benefits, Considerations and a Promising Future
32. FRAILTY IN MIDLIFE AS A PREDICTOR OF CHANGES IN BODY COMPOSITION FROM MIDLIFE INTO OLD AGE
33. Anticoagulant treatment and COVID‐19 mortality among older adults living in nursing homes in Sweden
34. Can markers of biological age predict dependency in old age?
35. Is frailty different in younger adults compared to old? Prevalence, characteristics and risk factors of early-life and late-life frailty in samples from Sweden and UK
36. Lung-protective ventilation suppresses systemic and hepatic vein levels of cell-free DNA in porcine experimental post-operative sepsis
37. Rare functional variants in the CRP and G6PC genes modify the relationship between obesity and serum C‐reactive protein in white British population
38. Automated frailty scores: towards clinical implementation
39. Unraveling the metabolic underpinnings of frailty using multicohort observational and Mendelian randomization analyses
40. Correction to: Deciphering the genetic and epidemiological landscape of mitochondrial DNA abundance
41. Comprehensive longitudinal study of epigenetic mutations in aging
42. Two Years with COVID-19 : The Electronic Frailty Index Identifies High-Risk Patients in the Stockholm GeroCovid Study
43. Health progression for Covid-19 survivors hospitalized in geriatric clinics in Sweden
44. Circulating miR-21, miR-146a and Fas ligand respond to postmenopausal estrogen-based hormone replacement therapy – A study with monozygotic twin pairs
45. Two Years with COVID-19: The Electronic Frailty Index Identifies High-Risk Patients in the Stockholm GeroCovid Study
46. Body composition in late midlife as a predictor of accelerated age-associated deficit accumulation from late midlife into old age: a longitudinal birth cohort study
47. Circulating cell-free DNA is associated with cardiometabolic risk factors: The Health 2000 Survey
48. Genetic and Environmental Influences on Longitudinal Frailty Trajectories From Adulthood into Old Age
49. Methylation status of VTRNA2-1/nc886 is stable across populations, monozygotic twin pairs and in majority of tissues
50. The pathogenesis of nephropathia epidemica: New knowledge and unanswered questions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.